U.S. Ambulatory Surgery Center Market Latest Innovations And Challenges By 2030

U.S. Ambulatory Surgery Center Market Summary

The U.S. ambulatory surgery center (ASC) market size was estimated at USD 40.41 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.02% from 2024 to 2030. Meanwhile, the U.S. ambulatory surgery center devices market was valued at USD 26.57 billion in 2023 and is expected to grow at a CAGR of 8.89% during the same forecast period.

This market expansion is largely driven by increased investments in ASCs and favorable reimbursement frameworks. For example, in January 2024, Tarrant Capital IP, LLC, an asset management firm, announced a strategic investment in Compass Surgical Partners—an independent, full-service ASC management and development partner. This capital infusion is intended to accelerate Compass Surgical Partners’ growth trajectory, broaden its operational capabilities, and enhance its ability to respond to growing interest in ASC joint ventures among healthcare system stakeholders.

Ambulatory services are playing an increasingly critical role in improving the U.S. healthcare delivery system by offering more accessible, efficient, and cost-effective options for patients and providers. A significant decline in inpatient admissions has occurred as more procedures are transferred to ASCs. Currently, more than 65% of all surgeries in the U.S. are performed in ASCs.

This shift is primarily influenced by the high costs associated with inpatient hospital stays and the adoption of advanced medical technologies by ASCs that enable quicker and more affordable treatments. Moreover, the increasing pressure from payers and Medicare has led many patients to choose local ambulatory community care units for diagnostic procedures, avoiding the higher expenses and longer wait times associated with larger hospital systems.

Key Market Trends & Insights

• In 2023, the orthopedics segment led the ASC market with a revenue share of 27.23%. This dominance can be attributed to the rapid development of diagnostic and imaging technologies in the orthopedic field and continuous innovations by leading industry players. These advancements have enabled more orthopedic procedures to be safely and efficiently performed in outpatient settings, which has contributed to the growth of this segment.
• The physician-owned segment held the largest market share of 62.16% in 2023. These centers typically focus on a limited range of procedures conducted within a single facility, allowing for greater operational efficiency. Physician ownership allows for direct oversight of the clinical process, which enhances decision-making and patient care, as the physicians are intimately familiar with each case and can tailor treatment accordingly. This model also ensures better alignment of clinical and financial incentives, making physician-owned ASCs highly appealing in the current healthcare environment.
• The single-specialty segment dominated the market in 2023, accounting for a share of 61.29%. This can be credited to the large number of single-specialty ASCs across the U.S., where commonly performed surgeries include cataract procedures, hernia repairs, joint replacements, colonoscopies, and various other minimally invasive interventions. Single-specialty centers benefit from streamlined workflows, lower costs, and specialized staff, which allow for improved clinical outcomes and patient satisfaction.
• Within the devices market, the orthopedic segment led with a market share of 31.37% in 2023. This growth reflects a broader transition of orthopedic procedures from hospitals to ASCs, a trend that was further accelerated by the COVID-19 pandemic. Additionally, Medicare’s increasing willingness to reimburse orthopedic procedures carried out in ASCs has played a pivotal role in encouraging the shift. The convenience and efficiency of ASCs for orthopedic surgeries have contributed to their growing popularity among both patients and providers.
• Regionally, the Southeast U.S. dominated the ambulatory surgery center market in 2023 with a revenue share of 29.16%. This dominance can be linked to the rising popularity of outpatient surgeries and the prevalence of physician-owned ASCs in the region. A notable development occurred in September 2022 when Intermountain Healthcare inaugurated a state-of-the-art ASC in St. George, further enhancing the region’s outpatient care infrastructure and signaling growing investment in ASC facilities.
• The Midwest region is expected to register the highest CAGR over the forecast period. The growth in this region is being propelled by numerous advancements in ASC technology, improved patient experiences, and the continuous modernization of outpatient medical procedures. Enhanced healthcare delivery systems, combined with regional initiatives to improve access to quality care, are positioning the Midwest as a rapidly expanding hub for ambulatory surgical services.

Order a free sample PDF of the U.S. Ambulatory Surgery Center Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 40.41 billion
• 2030 Projected Market Size: USD 49.08 billion
• CAGR (2024 - 2030): 6.02%

Key Companies & Market Share Insights

The demand for ASCs has led to increased competition among companies in the market. Furthermore, increasing industry consolidation activities, such as partnership & collaboration, acquisitions, and mergers, by the top market players as well as growing initiatives in launching new products by key players are also anticipated to increase their share in the market.

Key Players

Service Providers:

• Envision Healthcare Corporation (KKR & CO. Inc.) LLC
• Tenet Healthcare Corporation
• Mednax Services, Inc. (Pediatrix Medical Group, Inc.)
• TeamHealth
• UnitedHealth Group.
• Quorum Health
• Surgery Partners
• Community Health Systems, Inc.
• SurgCenter
• Prospect Medical Systems
• Edward-Elmhurst Health

Manufacturers

• McKesson Corp.
• BD.
• Koninklijke Philips N.V.
• 3M
• Olympus America
• Abbott
• Medtronic
• Zimmer Biomet
• Henry Schein, Inc.
• STERIS Plc

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. ambulatory surgery center market is poised for steady growth, driven by rising investments, favorable reimbursement policies, and the increasing shift of surgical procedures from hospitals to outpatient facilities. ASCs offer cost-effective, efficient, and patient-friendly alternatives, particularly in orthopedics and other minimally invasive specialties. Physician ownership and single-specialty centers are central to market dynamics, offering focused care and operational control. Regional developments, particularly in the Southeast and Midwest, signal growing national adoption. As healthcare continues evolving toward outpatient models supported by advanced devices and technologies, ASCs are expected to play a pivotal role in reshaping the future of surgical care delivery.